Somatuline Autogel
(RUGAHXUZHWYHNG-NLGNTGLNSA-N)
Structure
- SMILES
- CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2.NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2
- Molecular Formula:
- C118H158N22O30S4
- Molecular Weight:
- 2492.910
- Log P:
- 11.1511
- Hydrogen Bond Acceptor:
- 54
- Hydrogen Bond Donor:
- 31
- TPSA:
- 997.86
- CAS Number(s):
- N/A
Synonym(s)
1.
Somatuline Autogel
External Link(s)
| PubChem Compound | 91668159 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | FAERS: 32 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 2 | Malaise | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Asthenia | FAERS: 25 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Fatigue | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Nausea | FAERS: 24 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 6 | Inappropriate schedule of drug administration | FAERS: 23 | US FAERS | |
| 7 | Inappropriate schedule of product administration | FAERS: 22 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 8 | Dizziness | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 9 | Vomiting | FAERS: 18 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 10 | Disease Progression | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 11 | Pain | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Flatulence | FAERS: 14 | US FAERS | |
| 13 | Weight decreased | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 14 | Cholelithiasis | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Product dose omission | FAERS: 12 | US FAERS | |
| 16 | Injection site pain | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Headache | FAERS: 8 | US FAERS | |
| 18 | Back Pain | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Chills | FAERS: 7 | US FAERS | |
| 20 | Injection site mass | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Intestinal Obstruction | FAERS: 7 | US FAERS | |
| 22 | Peripheral swelling | FAERS: 7 | US FAERS | |
| 23 | Alopecia | FAERS: 6 | US FAERS | |
| 24 | Anxiety | FAERS: 6 | US FAERS | |
| 25 | Chest Pain | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 26 | Constipation | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 27 | Feeling abnormal | FAERS: 6 | US FAERS | |
| 28 | Flushing | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Nasopharyngitis | FAERS: 6 | US FAERS | |
| 30 | Pancreatitis | FAERS: 6 | US FAERS | |
| 31 | Arthralgia | FAERS: 5 | US FAERS | |
| 32 | Biliary sepsis | FAERS: 5 | US FAERS | |
| 33 | Blood glucose decreased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Blood glucose increased | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 35 | Depressed mood | FAERS: 5 | US FAERS | |
| 36 | Drug ineffective | FAERS: 5 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 37 | Hospice Care | FAERS: 5 | US FAERS | |
| 38 | Incorrect route of drug administration | FAERS: 5 | US FAERS | |
| 39 | Myalgia | FAERS: 5 | US FAERS | |
| 40 | Abdominal discomfort | FAERS: 4 | US FAERS | |
| 41 | Chest discomfort | FAERS: 4 | US FAERS | |
| 42 | Dyspepsia | FAERS: 4 | US FAERS | |
| 43 | Gait inability | FAERS: 4 | US FAERS | |
| 44 | General physical health deterioration | FAERS: 4 | US FAERS | |
| 45 | Lethargy | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 46 | Lower respiratory tract infection | FAERS: 4 | US FAERS | |
| 47 | Syncope | FAERS: 4 | US FAERS | |
| 48 | Tremor | FAERS: 4 | US FAERS | |
| 49 | Angioedema | FAERS: 3 | US FAERS | |
| 50 | Blood potassium decreased | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Cataract | FAERS: 3 | US FAERS | |
| 52 | Cholecystitis infective | FAERS: 3 | US FAERS | |
| 53 | Deep Vein Thrombosis | FAERS: 3 | US FAERS | |
| 54 | Dehydration | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 55 | Dementia | FAERS: 3 | US FAERS | |
| 56 | Diabetes Mellitus | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 57 | Discomfort | FAERS: 3 | US FAERS | |
| 58 | Disorientation | FAERS: 3 | US FAERS | |
| 59 | Eating disorder symptom | FAERS: 3 | US FAERS | |
| 60 | Incorrect product administration duration | FAERS: 3 | US FAERS | |
| 61 | Incorrect route of product administration | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 62 | Infection | FAERS: 3 | US FAERS | |
| 63 | Loss of personal independence in daily activities | FAERS: 3 | US FAERS | |
| 64 | Palliative Care | FAERS: 3 | US FAERS | |
| 65 | Palpitations | FAERS: 3 | US FAERS | |
| 66 | Terminal state | FAERS: 3 | US FAERS | |
| 67 | Therapy cessation | FAERS: 3 | US FAERS | |
| 68 | Urinary tract infection | FAERS: 3 | US FAERS | |
| 69 | Ammonia increased | FAERS: 2 | US FAERS | |
| 70 | Amylase increased | FAERS: 2 | US FAERS | |
| 71 | Cerebrovascular accident | FAERS: 2 | US FAERS | |
| 72 | Chromaturia | FAERS: 2 | US FAERS | |
| 73 | Cold sweat | FAERS: 2 | US FAERS | |
| 74 | Colectomy | FAERS: 2 | US FAERS | |
| 75 | Colitis | FAERS: 2 | US FAERS | |
| 76 | Cyst | FAERS: 2 | US FAERS | |
| 77 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 78 | Device occlusion | FAERS: 2 | US FAERS | |
| 79 | Dysgeusia | FAERS: 2 | US FAERS | |
| 80 | Eructation | FAERS: 2 | US FAERS | |
| 81 | Facial paralysis | FAERS: 2 | US FAERS | |
| 82 | Hyperphagia | FAERS: 2 | US FAERS | |
| 83 | Hypotension | FAERS: 2 | US FAERS | |
| 84 | Impaired self-care | FAERS: 2 | US FAERS | |
| 85 | Infectious Mononucleosis | FAERS: 2 | US FAERS | |
| 86 | Injection site pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Intentional dose omission | FAERS: 2 | US FAERS | |
| 88 | Joint injury | FAERS: 2 | US FAERS | |
| 89 | Malignant neoplasm progression | FAERS: 2 | US FAERS | |
| 90 | Memory impairment | FAERS: 2 | US FAERS | |
| 91 | Metastasis | FAERS: 2 | US FAERS | |
| 92 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 93 | Oncologic complication | FAERS: 2 | US FAERS | |
| 94 | Oropharyngeal pain | FAERS: 2 | US FAERS | |
| 95 | Pneumonia | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 96 | Presyncope | FAERS: 2 | US FAERS | |
| 97 | Product prescribing issue | FAERS: 2 | US FAERS | |
| 98 | Pulmonary Embolism | FAERS: 2 | US FAERS | |
| 99 | Scan abnormal | FAERS: 2 | US FAERS | |
| 100 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 101 | Thrombosis | FAERS: 2 | US FAERS | |
| 102 | Trichorrhexis | FAERS: 2 | US FAERS | |
| 103 | Urticaria | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | skin abrasion | FAERS: 2 | US FAERS | |
| 105 | Abasia | FAERS: 1 | US FAERS | |
| 106 | Adverse event | FAERS: 1 | US FAERS | |
| 107 | Amnesia | FAERS: 1 | US FAERS | |
| 108 | Anal abscess | FAERS: 1 | US FAERS | |
| 109 | Ankle Fracture | FAERS: 1 | US FAERS | |
| 110 | Application site acne | FAERS: 1 | US FAERS | |
| 111 | Arthritis | FAERS: 1 | US FAERS | |
| 112 | Ascites | FAERS: 1 | US FAERS | |
| 113 | Blood chromogranin A increased | FAERS: 1 | US FAERS | |
| 114 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 115 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 116 | Blood sodium decreased | FAERS: 1 | US FAERS | |
| 117 | Blood thyroid stimulating hormone decreased | FAERS: 1 | US FAERS | |
| 118 | Blood urine present | FAERS: 1 | US FAERS | |
| 119 | Bradycardia | FAERS: 1 | US FAERS | |
| 120 | Cachexia | FAERS: 1 | US FAERS | |
| 121 | Cancer Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Carcinoid Heart Disease | FAERS: 1 | US FAERS | |
| 123 | Carcinoid crisis | FAERS: 1 | US FAERS | |
| 124 | Cellulitis | FAERS: 1 | US FAERS | |
| 125 | Cholecystitis | FAERS: 1 | US FAERS | |
| 126 | Cholelithiasis obstructive | FAERS: 1 | US FAERS | |
| 127 | Delirium | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 128 | Device leakage | FAERS: 1 | US FAERS | |
| 129 | Device related infection | FAERS: 1 | US FAERS | |
| 130 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 131 | Drooling | FAERS: 1 | US FAERS | |
| 132 | Drug administered at inappropriate site | FAERS: 1 | US FAERS | |
| 133 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 134 | Dry skin | FAERS: 1 | US FAERS | |
| 135 | Dysphonia | FAERS: 1 | US FAERS | |
| 136 | Embolism | FAERS: 1 | US FAERS | |
| 137 | Endoscopic Retrograde Cholangiopancreatography | FAERS: 1 | US FAERS | |
| 138 | Epilepsy | FAERS: 1 | US FAERS | |
| 139 | Epistaxis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 140 | Erythema | FAERS: 1 | US FAERS | |
| 141 | Feeling Cold | FAERS: 1 | US FAERS | |
| 142 | Feeling of body temperature change | FAERS: 1 | US FAERS | |
| 143 | Flank Pain | FAERS: 1 | US FAERS | |
| 144 | Food Poisoning | FAERS: 1 | US FAERS | |
| 145 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 146 | Gastrointestinal carcinoma | FAERS: 1 | US FAERS | |
| 147 | Gastrointestinal infection | FAERS: 1 | US FAERS | |
| 148 | Gastrointestinal mucosal disorder | FAERS: 1 | US FAERS | |
| 149 | General physical condition abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 150 | Hepatic Encephalopathy | FAERS: 1 | US FAERS | |
| 151 | Hepatic Infection | FAERS: 1 | US FAERS | |
| 152 | Hepatic Vein Thrombosis | FAERS: 1 | US FAERS | |
| 153 | Hepatic artery embolism | FAERS: 1 | US FAERS | |
| 154 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 155 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 156 | Hyperpyrexia | FAERS: 1 | US FAERS | |
| 157 | Hypersomnia | FAERS: 1 | US FAERS | |
| 158 | Hypophagia | FAERS: 1 | US FAERS | |
| 159 | Hypothalamo-pituitary disorder | FAERS: 1 | US FAERS | |
| 160 | Hypoventilation | FAERS: 1 | US FAERS | |
| 161 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 162 | Influenza | FAERS: 1 | US FAERS | |
| 163 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 164 | Injection site abscess | FAERS: 1 | US FAERS | |
| 165 | Injection site erythema | FAERS: 1 | US FAERS | |
| 166 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 167 | Injection site irritation | FAERS: 1 | US FAERS | |
| 168 | Injection site necrosis | FAERS: 1 | US FAERS | |
| 169 | Injection site ulcer | FAERS: 1 | US FAERS | |
| 170 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 171 | Insulin-like growth factor increased | FAERS: 1 | US FAERS | |
| 172 | Intestinal Perforation | FAERS: 1 | US FAERS | |
| 173 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 174 | Joint swelling | FAERS: 1 | US FAERS | |
| 175 | Lack of injection site rotation | FAERS: 1 | US FAERS | |
| 176 | Laryngitis | FAERS: 1 | US FAERS | |
| 177 | Living in residential institution | FAERS: 1 | US FAERS | |
| 178 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 179 | Lymphoma | FAERS: 1 | US FAERS | |
| 180 | Malignant neoplasm of spinal cord | FAERS: 1 | US FAERS | |
| 181 | Mastitis | FAERS: 1 | US FAERS | |
| 182 | Meningitis | FAERS: 1 | US FAERS | |
| 183 | Mental Fatigue | FAERS: 1 | US FAERS | |
| 184 | Metastatic Neoplasm | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 185 | Muscle tightness | FAERS: 1 | US FAERS | |
| 186 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 187 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 188 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 189 | Needle issue | FAERS: 1 | US FAERS | |
| 190 | Neuralgia | FAERS: 1 | US FAERS | |
| 191 | Nocturia | FAERS: 1 | US FAERS | |
| 192 | Nodule | FAERS: 1 | US FAERS | |
| 193 | Oral candidiasis | FAERS: 1 | US FAERS | |
| 194 | Orchitis | FAERS: 1 | US FAERS | |
| 195 | Otitis Externa | FAERS: 1 | US FAERS | |
| 196 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 197 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 198 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 199 | Performance status decreased | FAERS: 1 | US FAERS | |
| 200 | Product storage error | FAERS: 1 | US FAERS | |
| 201 | Product use issue | FAERS: 1 | US FAERS | |
| 202 | Pulmonary congestion | FAERS: 1 | US FAERS | |
| 203 | Pulmonary thrombosis | FAERS: 1 | US FAERS | |
| 204 | Quality of life decreased | FAERS: 1 | US FAERS | |
| 205 | Rales | FAERS: 1 | US FAERS | |
| 206 | Rash erythematous | FAERS: 1 | US FAERS | |
| 207 | Respiratory distress | FAERS: 1 | US FAERS | |
| 208 | Respiratory muscle weakness | FAERS: 1 | US FAERS | |
| 209 | Retching | FAERS: 1 | US FAERS | |
| 210 | Rheumatic disorder | FAERS: 1 | US FAERS | |
| 211 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 212 | Scan abdomen abnormal | FAERS: 1 | US FAERS | |
| 213 | Sciatica | FAERS: 1 | US FAERS | |
| 214 | Secretion discharge | FAERS: 1 | US FAERS | |
| 215 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 216 | Skin laceration | FAERS: 1 | US FAERS | |
| 217 | Stress | FAERS: 1 | US FAERS | |
| 218 | Subcutaneous Abscess | FAERS: 1 | US FAERS | |
| 219 | Tachyarrhythmia | FAERS: 1 | US FAERS | |
| 220 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 221 | Tinea Pedis | FAERS: 1 | US FAERS | |
| 222 | Tinnitus | FAERS: 1 | US FAERS | |
| 223 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 224 | Umbilical hernia | FAERS: 1 | US FAERS | |
| 225 | Ureteral stent insertion | FAERS: 1 | US FAERS | |
| 226 | Ureterolithiasis | FAERS: 1 | US FAERS | |
| 227 | Uterine Polyp | FAERS: 1 | US FAERS | |
| 228 | Visual Impairment | FAERS: 1 | US FAERS | |
| 229 | Vulvovaginal pruritus | FAERS: 1 | US FAERS | |
| 230 | Wound Infection | FAERS: 1 | US FAERS | |
| 231 | Wrong drug administered | FAERS: 1 | US FAERS | |
| 232 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 233 | Abdominal Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 234 | Arthropathy | Canada Vigilance: 1 | Canada Vigilance | |
| 235 | Breast Cyst | Canada Vigilance: 1 | Canada Vigilance | |
| 236 | Choking | Canada Vigilance: 1 | Canada Vigilance | |
| 237 | Dark circles under eyes | Canada Vigilance: 1 | Canada Vigilance | |
| 238 | Diabetic Ketoacidosis | Canada Vigilance: 1 | Canada Vigilance | |
| 239 | Gastrointestinal obstruction | Canada Vigilance: 1 | Canada Vigilance | |
| 240 | Hernia | Canada Vigilance: 1 | Canada Vigilance | |
| 241 | Lip swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 242 | Liver scan abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 243 | Macular degeneration | Canada Vigilance: 1 | Canada Vigilance | |
| 244 | Musculoskeletal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 245 | Pericarditis | Canada Vigilance: 1 | Canada Vigilance | |
| 246 | Product substitution issue | Canada Vigilance: 1 | Canada Vigilance | |
| 247 | Pyelonephritis | Canada Vigilance: 1 | Canada Vigilance | |
| 248 | Rhabdomyolysis | Canada Vigilance: 1 | Canada Vigilance | |
| 249 | Therapeutic product effect decreased | Canada Vigilance: 4 | Canada Vigilance | |
| 250 | Therapeutic product effect incomplete | Canada Vigilance: 1 | Canada Vigilance | |
| 251 | rhinoplasty | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.